Cargando…
ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model
ALS-L1023 is an ingredient extracted from Melissa officinalis L. (Labiatae; lemon balm), which is known as a natural medicine that suppresses angiogenesis. Herein, we aimed to determine whether ALS-L1023 could alleviate liver fibrosis in the non-alcoholic fatty liver disease (NAFLD) model. C57BL/6 w...
Autores principales: | Lee, Eun Jeoung, Kim, Yun, Kim, Ji Eun, Yoon, Eileen Laurel, Lee, Sung Ryol, Jun, Dae Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863634/ https://www.ncbi.nlm.nih.gov/pubmed/36676050 http://dx.doi.org/10.3390/life13010100 |
Ejemplares similares
-
Reduction of Adipose Tissue Mass by the Angiogenesis Inhibitor ALS-L1023 from Melissa officinalis
por: Park, Byung Young, et al.
Publicado: (2015) -
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ALS-L1023 in Non-Alcoholic Fatty Liver Disease
por: Kim, Gi-Ae, et al.
Publicado: (2023) -
Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver disease
por: Lee, Seung Min, et al.
Publicado: (2023) -
Melissa officinalis Extract Inhibits Laser-Induced Choroidal Neovascularization in a Rat Model
por: Lee, Eun Kyoung, et al.
Publicado: (2014) -
Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
por: Park, Huiyul, et al.
Publicado: (2022)